ICECURE MEDICAL LTD (ICCM)
IL0011224156 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.14M 6.98% | 3.09M -25.36% | 3.229M 4.50% | 3.553M 10.03% | 5.78M 62.68% | 9.789M 69.36% | 61.425M 527.49% | 88.729M 44.45% | 116.54M 31.34% | 144.86M 24.30% | 168.59M 16.38% | 183.7M 8.96% | |
| EBITDA YoY % growth | -9.59M -135.05% | -16.49M -71.95% | -15.253M 7.50% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.72M -134.78% | -16.74M -72.22% | -15.576M 6.95% | -15.609M -0.21% | -15.714M -0.67% | -12.691M 19.24% | 12.285M 196.80% | 17.746M 44.45% | 23.307M 31.34% | 30.419M 30.51% | 37.09M 21.93% | 42.25M 13.91% | |
| Operating Margin | -234.78% | -541.75% | -482.38% | -439.32% | -271.86% | -129.64% | 20.00% | 20.00% | 20.00% | 21.00% | 22.00% | 23.00% | |
| EPS YoY % growth | N/A | N/A -54.31% | -0.31 31.65% | -0.30 3.56% | -0.27 11.86% | -0.21 19.23% | 0.23 209.52% | 0.34 43.48% | 0.44 30.30% | 0.57 30.23% | 0.51 -10.71% | 0.57 12.00% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 -17.69% | -0.07 10.75% | -0.06 -2.00% | -0.06 23.50% | -0.06 26.67% |
| Revenue Q2Q % growth | 1.089M -13.23% | 971.55K 30.76% | 1.284M 27.00% | 1.471M 122.21% | 2.08M 91.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.924M -14.90% | -3.964M -8.60% | -3.758M -16.41% | -3.703M 13.75% | -3.357M 14.45% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.08 8.05% | -0.08 | 0.00 | -4.58% |
| Q2 2024 Q2Q % growth | -0.06 25.00% | -0.07 | 0.01 | 15.97% |
| Q1 2024 Q2Q % growth | -0.08 | -0.08 | 0.00 | 1.96% |
| Q4 2023 Q2Q % growth | -0.07 40.91% | -0.07 | 0.01 | 8.96% |
| Q3 2023 Q2Q % growth | -0.09 20.91% | -0.09 | 0.00 | 5.23% |
| Q2 2023 Q2Q % growth | -0.08 33.33% | -0.09 | 0.01 | 9.51% |
| Q1 2023 Q2Q % growth | -0.08 | -0.10 | 0.02 | 15.96% |
| Q4 2022 Q2Q % growth | -0.11 | -0.11 | 0.00 | -4.37% |
| Q3 2022 Q2Q % growth | -0.11 | -0.12 | 0.01 | 6.22% |
| Q2 2022 Q2Q % growth | -0.12 | -0.12 | 0.00 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 662K 106.88% | 722.67K | -60.67K | -8.40% |
| Q2 2024 Q2Q % growth | 1.011M 7.55% | 944.01K | 66.99K | 7.10% |
| Q1 2024 Q2Q % growth | 743K 4.65% | 893.01K | -150.01K | -16.80% |
| Q4 2023 Q2Q % growth | 1.255M 33.51% | 1.19M | 65K | 5.46% |
| Q3 2023 Q2Q % growth | 320K -49.21% | 1.042M | -722K | -69.29% |
| Q2 2023 Q2Q % growth | 940K 22.08% | 959.137K | -19.137K | -2.00% |
| Q1 2023 Q2Q % growth | 710K -5.33% | 983.617K | -273.617K | -27.82% |
| Q4 2022 Q2Q % growth | 940K | 1.016M | -76K | -7.48% |
| Q3 2022 Q2Q % growth | 630K | 936.36K | -306.36K | -32.72% |
| Q2 2022 Q2Q % growth | 770K 20.31% | 838.44K | -68.44K | -8.16% |
| Q1 2022 Q2Q % growth | 750K -47.92% | % | ||
| Q2 2021 Q2Q % growth | 640K -65.03% | % | ||
| Q4 2020 Q2Q % growth | 1.99M 87.74% | % | ||
| Q2 2020 Q2Q % growth | 1.83M 226.79% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -3.51% | -3.51% |
| Revenue | 0% | -14.05% | -7.23% | -7.23% |